Ionis Pharmaceuticals | Passifs Courants



Current Liabilities Changement Date
Adcock Ingram Holdings ZAR 2.53B 85.57M 2024-06
Agios Pharmaceuticals USD 81.16M 38.3M 2024-12
Alnylam Pharmaceuticals USD 1.19B 34.39M 2024-12
Arrowhead Research USD 93.76M 9.41M 2024-12
Astellas Pharma JPY 1.15T 59.2B 2024-12
BioMarin Pharmaceutical USD 606.99M 108.67M 2024-12
Celltrion KRW 3.03T 141.48B 2024-09
Cspc Pharmaceutical CNY 9.63B 801.28M 2024-12
Ecofibre AUD 20.78M 803K 2024-06
Exelixis USD 403.77M 9.42M 2025-01
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
Ionis Pharmaceuticals USD 309.32M 4.75M 2024-12
Kangmei Pharma CNY 4.91B 208.41M 2024-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 156.65M 115.81M 2024-12
Malin Corporation EUR 500K 500K 2024-06
Medical Developments International AUD 9.55M 1.61M 2024-06
Moderna USD 2.21B 5M 2024-12
Neuren Pharmaceuticals AUD 45.76M 36.79M 2024-12
Neurocrine Biosciences USD 507.7M 78M 2024-12
Novartis USD 28.69B 560M 2024-12
OPKO Health USD 193.1M 18.56M 2024-12
Organigram Holdings CAD 68.96M 15.64M 2024-12
Pfizer USD 43B 216M 2024-12
Pharma Mar EUR 82.69M 6.75M 2024-12
PTC Therapeutics USD 580.98M 29.73M 2024-12
Qiagen NV USD 543.63M 584.94M 2024-12
Regeneron Pharmaceuticals USD 5.7B 2.04B 2024-12
Roche Holding CHF 27.02B 424M 2024-12
Sarepta Therapeutics USD 731.68M 32.2M 2024-12
Sartorius EUR 977M 116.3M 2024-09
Sino Biopharmaceutical CNY 19.56B 2.39B 2024-12
Tilray USD 278.52M 15.02M 2024-11
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12
Zz Pientze Pharmaceu 3.1B 569.38M 2024-09



Ionis Pharmaceuticals Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.